Immunohistochemical staining (IHC) on these tumour tissues using S-100, CD56 and calretinin was done and scoring was done based on extent and intensity.<h4>Results and discussion</h4> No significant differences were observed between neurofibromas and schwannomas on patient age and anatomical locations of these tumours. This evidence concerns the gene CALB2 and plexiform neurofibroma.